May 19, 2020
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy(TM) (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
May 15, 2020
Stars Come Together to Help Kids with Rare Genetic Disorder That Causes Tumors
May 07, 2020
Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
Apr 30, 2020
InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755
Apr 27, 2020
Eiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid Laminopathies
Apr 01, 2020
InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Mar 24, 2020
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial
Mar 23, 2020
Lamellar Ichthyosis (LI) Industry Outlook, 2030 Featuring Emerging Drugs TMB-001, Trifarotene (CD5789), and KB105
Mar 23, 2020
Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
Mar 20, 2020
InMed Provides Update on Operations in Response to the COVID-19 Global Outbreak
Mar 13, 2020
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Mar 10, 2020
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Mar 03, 2020
Lipidio Pharmaceuticals Launches with First Close of Series A Financing
Feb 14, 2020
GeneTx Announces IRB Approval to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome
Jan 24, 2020
Prader-Willi Syndrome Pipeline Study, H1 2020 - Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type
Jan 21, 2020
InMed Expands on Announcement of Cannabinol (CBN) Therapeutic Leadership with New Website Content and CEO Interview
Jan 20, 2020
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
Jan 16, 2020
InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress
Jan 10, 2020
IDEAYA Biosciences and Boston Children's Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome - a Rare Disease Associated with Genetic Mutation of GNAQ
Jan 07, 2020
Aegle Therapeutics Announces $4M Financing to Fund Groundbreaking Stem Cell Exosome Clinical Trial to Treat Orphan Disease Dystrophic Epidermolysis Bullosa